|Bid||9.72 x 4000|
|Ask||15.96 x 1100|
|Day's Range||9.98 - 9.98|
|52 Week Range||9.70 - 10.25|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Eve & Co Incorporated ("Eve & Co" or the "Company") (NEX: EVE.H) (OTCQX: EEVVF) announces that effective as of March 30, 2022, the Company's listing has been transferred to NEX for failing to maintain the requirements of a TSX Venture Tier 1 Company and further to the TSX Venture Exchange (the "Exchange") Bulletin dated March 24, 2022 and the Company's press releases dated March 25, 2022, trading in the shares of the Company have been suspended effective as of opening at March 30, 2022 for failu
Eve & Co Incorporated ("Eve & Co" or the "Company") (TSXV: EVE) (OTCQX: EEVVF) announces that in connection with the resignations of Ravi Sood and Jeanette VanderMarel as directors of Eve & Co on March 22, 2022 and March 23, 2022, respectively, the TSX Venture Exchange (the "Exchange") has suspended trading in the Company's securities for failure to maintain Exchange requirements to maintain a minimum of three directors on the board of the Company at all times.
Eve & Co Incorporated ("Eve & Co" or the "Company") (TSXV: EVE) (OTCQX: EEVVF) announces today that the Company and its subsidiaries, Natural MedCo Ltd. ("NMC") and Eve & Co International Holdings Ltd. ("Eve International" and together with Eve & Co and NMC, the "Eve Group") received an order for creditor protection (the "Initial Order") from the Ontario Superior Court of Justice (Commercial List) (the "Court") under the Companies' Creditors Arrangement Act (the "CCAA").